Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-13

Clinical Trial Update: Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs

View source ↗

Summary

This clinical trial update reports the withdrawal of a study evaluating oral glucose tolerance testing in patients treated with somatostatin analogs for acromeg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Acromegaly | Status: WITHDRAWN